Definitive Contract 75A50122C00050
Award Date
9/12/22
Potential Completion Date
4/30/27
Potential Value
$37M
Awardee
Asell, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Owings Mills, MD, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive, cost-no-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Cleveland Biolabs, Inc. to develop a therapy for hematopoietic syndrome resulting from acute radiation exposure. The contract, which does not have a set-aside designation, has a ceiling value of $21,956,799.00 and an ultimate completion date of October 15, 2010. As the prime contractor, Cleveland Biolabs, Inc. is responsible for delivering the...
This is a $17,325,268.78 cost-plus-fixed-fee contract awarded to Biofire Defense LLC on September 29, 2023 by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract objective is to advance the development of Biofire's Emerging Flu Panel as a nucleic acid detection assay for use on the Biofire FilmArray Torch and Spotfire platforms. This work is related to a previous Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA)...
This is a $1,764,756.57 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The order was issued under the Biomedical Advanced Research and Development Authority (BARDA) Chem and RadNuc Animal Model 2015-2020 IDIQ contract. The purpose is to conduct a non-primate animal model study on host biomarker...
This $4,175,467 definitive cost-no-fee contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Pluri Biotech LTD, a for-profit limited liability company based in Israel, for the development of PLX-R18 cell therapy as a countermeasure for hematopoietic acute radiation syndrome. The contract, which has no set-aside designation, supports research and development efforts focused on creating safe and effective medical countermeasures to mitigate...
This is a $9,050,674.00 definitive cost-sharing contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a self-certified small disadvantaged business. The contract is for advancing Cytovale's biophysical early sepsis diagnostic towards U.S. Food and Drug Administration (FDA) 510(k) clearance. This contract was awarded under a Broad Agency Announcement (BAA) from the Biomedical Advanced Research...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Meabco Inc. for the "ERMES EVALUATION OF RADIOMITIGATIVE EFFICACY AND SAFETY OF BP-C2" project. The contract has a ceiling value of $6,434,348.32 and a period of performance ending on April 30, 2025. The contract stems from a Broad Agency Announcement (BAA) seeking proposals to develop safe and effective medical countermeasures to...
<p>This is a $84,999,847.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Salzman Group, Inc., a woman-owned small business. The contract, which does not have a set-aside designation, has an ultimate completion date of August 31, 2023. The contract provides for the delivery of goods or services, though the specific requirements are not provided in the information given.</p>
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $74,984,180.00 cost-plus-fixed-fee definitive contract to Spectral MD, Inc. for the development of a portable optical imaging device and machine learning algorithm to classify burn injuries. This contract was awarded under ASPR's Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement that seeks advanced research and development of...
This is a $228,598,975.00 definitive cost-sharing contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janssen Research & Development, LLC. The contract was issued under ASPR's Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) focused on the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and...
This is a $725,368.36 Firm Fixed Price (FFP) contract awarded to Beckman Coulter, Inc., a subsidiary of Danaher Corporation, by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract is for a research and development effort to develop a rapid detection test for severe, dysregulated host immune response to infection in pediatrics. The contract has a base period of performance through September 30, 2025 and was awarded on June 30, 2022. This contract was issued...